173 related articles for article (PubMed ID: 27682967)
1. Idiopathic nephrotic syndrome: the EBV hypothesis.
Dossier C; Jamin A; Deschênes G
Pediatr Res; 2017 Jan; 81(1-2):233-239. PubMed ID: 27682967
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.
Jamin A; Dehoux L; Dossier C; Fila M; Heming N; Monteiro RC; Deschênes G
Clin Exp Immunol; 2015 Dec; 182(3):332-45. PubMed ID: 26123900
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.
Jamin A; Berthelot L; Couderc A; Chemouny JM; Boedec E; Dehoux L; Abbad L; Dossier C; Daugas E; Monteiro RC; Deschênes G
J Autoimmun; 2018 May; 89():149-161. PubMed ID: 29307588
[TBL] [Abstract][Full Text] [Related]
4. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
5. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.
Kim AH; Chung JJ; Akilesh S; Koziell A; Jain S; Hodgin JB; Miller MJ; Stappenbeck TS; Miner JH; Shaw AS
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093269
[TBL] [Abstract][Full Text] [Related]
6. B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.
Colucci M; Carsetti R; Cascioli S; Casiraghi F; Perna A; Ravà L; Ruggiero B; Emma F; Vivarelli M
J Am Soc Nephrol; 2016 Jun; 27(6):1811-22. PubMed ID: 26567244
[TBL] [Abstract][Full Text] [Related]
7. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome.
Garin EH; Laflam PF; Muffly K
Nephron Exp Nephrol; 2006; 102(3-4):e105-12. PubMed ID: 16330882
[TBL] [Abstract][Full Text] [Related]
11. Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome.
Musante L; Candiano G; Bruschi M; Santucci L; Carnemolla B; Orecchia P; Giampuzzi M; Zennaro C; Sanna-Cherchi S; Carraro M; Oleggini R; Camussi G; Perfumo F; Ghiggeri GM
Clin Exp Immunol; 2005 Sep; 141(3):491-9. PubMed ID: 16045739
[TBL] [Abstract][Full Text] [Related]
12. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
[TBL] [Abstract][Full Text] [Related]
14. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.
Babcock GJ; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12250-5. PubMed ID: 11035774
[TBL] [Abstract][Full Text] [Related]
15. EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants.
Lorenzetti MA; Altcheh J; Moroni S; Moscatelli G; Chabay PA; Preciado MV
J Med Virol; 2010 Oct; 82(10):1730-8. PubMed ID: 20827771
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
Murakami M; Lan K; Subramanian C; Robertson ES
J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
[TBL] [Abstract][Full Text] [Related]
17. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.
Yin Q; Flemington EK
Virology; 2006 Mar; 346(2):385-93. PubMed ID: 16343579
[TBL] [Abstract][Full Text] [Related]
18. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
[TBL] [Abstract][Full Text] [Related]
19. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes.
Sears J; Ujihara M; Wong S; Ott C; Middeldorp J; Aiyar A
J Virol; 2004 Nov; 78(21):11487-505. PubMed ID: 15479791
[TBL] [Abstract][Full Text] [Related]
20. The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal.
Chao M; Wang HN; Lu YJ; Chang YS; Yu JS
Oncol Rep; 2015 Feb; 33(2):958-66. PubMed ID: 25434292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
